Michael Soyka Selected Research

Therapeutics

1/2023	[Acceptance and use of web-based interventions for alcohol abstinence].
1/2023	Concomitant Drug Use among Opioid-Dependent Patients with and without Attention Deficit Hyperactivity Disorder: Does Methylphenidate Merit a Trial?
9/2020	Dextromethorphan Abuse Among Opioid-Dependent Patients.
11/2019	Pain management in opioid maintenance treatment.
1/2019	Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.
1/2019	Interrelationship of Opioid Dependence, Impaired Impulse Control, and Depressive Symptoms: An Open-Label Cross-Sectional Study of Patients in Maintenance Therapy.
12/2018	Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.
1/2018	[Stress Response in Persons with Alcohol Addiction in the Context of Abstinence Duration and Disease Severity].
12/2017	Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.
2/2017	[Prevalence and Therapy of Crystal Methamphetamine Dependence].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Soyka Research Topics

Disease

40	Alcoholism (Alcohol Abuse) 01/2023 - 01/2002
28	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 01/2005
8	Fibrosis (Cirrhosis) 04/2023 - 01/2011
7	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2024 - 01/2004
7	Substance-Related Disorders (Drug Abuse) 09/2020 - 02/2003
6	Cognitive Dysfunction 11/2019 - 10/2005
4	Mental Disorders (Mental Disorder) 01/2021 - 02/2003
4	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2018 - 01/2011
4	Schizophrenia (Dementia Praecox) 01/2015 - 01/2005
3	Cocaine-Related Disorders (Cocaine Addiction) 01/2023 - 03/2016
3	Tobacco Use Disorder (Nicotine Dependence) 01/2018 - 03/2016
2	Respiratory Insufficiency (Respiratory Failure) 01/2024 - 01/2015
2	Non-alcoholic Fatty Liver Disease 04/2023 - 11/2014
2	Hepatocellular Carcinoma (Hepatoma) 04/2023 - 01/2021
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023 - 10/2018
2	Depressive Disorder (Melancholia) 04/2019 - 09/2017
2	Personality Disorders (Personality Disorder) 01/2018 - 09/2003
2	Infections 12/2017 - 04/2009
2	Hepatitis C 01/2005 - 02/2003
1	Seizures (Absence Seizure) 01/2024
1	Delirium 01/2024
1	Coma (Comas) 01/2024
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2023
1	Meningitis 03/2022
1	Mastoiditis 03/2022
1	Prediabetic State (Prediabetes) 01/2021
1	Obesity 01/2021
1	Weight Loss (Weight Reduction) 01/2021

Drug/Important Bio-Agent (IBA)

24	Methadone (Dolophine)FDA LinkGeneric 09/2021 - 02/2003
21	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2005
20	Buprenorphine (Subutex)FDA LinkGeneric 09/2021 - 01/2005
13	Naltrexone (ReVia)FDA LinkGeneric 01/2022 - 12/2002
9	Narcotic Antagonists (Opioid Antagonists)IBA 01/2022 - 01/2003
8	Acamprosate (Campral)FDA Link 01/2022 - 01/2002
5	BenzodiazepinesIBA 01/2024 - 01/2005
5	nalmefene (Revex)FDA Link 01/2022 - 11/2008
4	Heroin (Diamorphine)IBA 01/2023 - 08/2008
4	Topiramate (Topamax)FDA LinkGeneric 01/2022 - 08/2017
4	EnzymesIBA 01/2018 - 12/2002
4	Naloxone Drug Combination Buprenorphine FDA Link 02/2015 - 11/2012
3	Cocaine (Cocaine HCl)IBA 01/2023 - 04/2015
3	Disulfiram (Antabuse)FDA Link 01/2022 - 12/2010
3	Gabapentin (Neurontin)FDA LinkGeneric 01/2022 - 08/2017
3	Ethanol (Ethyl Alcohol)IBA 05/2017 - 04/2005
3	Antipsychotic Agents (Antipsychotics)IBA 02/2009 - 04/2003
2	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2024 - 01/2021
2	Opiate AlkaloidsIBA 01/2024 - 12/2022
2	Methylphenidate (Ritalin)FDA LinkGeneric 01/2023 - 10/2016
2	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 01/2022 - 04/2015
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 07/2008
2	Varenicline (Chantix)FDA Link 01/2022 - 08/2017
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 04/2019
2	RimonabantIBA 01/2022 - 06/2008
2	Neuropeptide YIBA 01/2022 - 03/2008
2	Transaminases (Aminotransferases)IBA 10/2020 - 01/2011
2	Protein Isoforms (Isoforms)IBA 10/2018 - 01/2009
2	BilirubinIBA 01/2018 - 09/2012
2	Naloxone (Narcan)FDA LinkGeneric 02/2015 - 09/2013
2	Methionine (L-Methionine)FDA Link 01/2015 - 09/2011
2	Opioid Receptors (Opioid Receptor)IBA 01/2015 - 07/2012
2	Dopamine (Intropin)FDA LinkGeneric 03/2012 - 09/2011
2	Alanine Transaminase (SGPT)IBA 01/2011 - 02/2003
1	4-amino-3-phenylbutyric acid (phenibut)IBA 01/2024
1	gamma-Aminobutyric Acid (GABA)IBA 01/2024
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 04/2023
1	Messenger RNA (mRNA)IBA 04/2023
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2023
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2023
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2023
1	Calcium Sulfate (Alabaster)IBA 03/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	Clozapine (Clozaril)FDA LinkGeneric 01/2022
1	Ondansetron (Zofran)FDA LinkGeneric 01/2022
1	Baclofen FDA LinkGeneric 01/2022
1	Mifepristone (RU 486)FDA Link 01/2022
1	LithiumIBA 01/2022
1	ifenprodilIBA 01/2022
1	Memantine (Namenda)FDA Link 01/2022
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	ibudilastIBA 01/2022
1	Investigational DrugsIBA 01/2022
1	Aripiprazole (Abilify)FDA Link 01/2022
1	NeuropeptidesIBA 01/2022
1	AM4113IBA 01/2022
1	3-carboxamido-4-hydroxynaltrexoneIBA 01/2022
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2022
1	surinabantIBA 01/2022
1	Cytidine Diphosphate Choline (Citicoline)IBA 01/2022
1	Corticotropin-Releasing HormoneIBA 01/2022
1	PF-5190457IBA 01/2022
1	1- (5- chloro- 1- ((2,4- dimethoxyphenyl)sulfonyl)- 3- (2- methoxyphenyl)- 2- oxo- 2,3- dihydro- 1H- indol- 3- yl)- 4- hydroxy- N,N- dimethyl- 2- pyrrolidinecarboxamideIBA 01/2022
1	TeaIBA 01/2021
1	Toll-Like Receptor 5IBA 01/2021
1	FlagellinIBA 01/2021

Therapy/Procedure

21	Therapeutics 01/2023 - 01/2002
10	Drug Therapy (Chemotherapy) 01/2023 - 04/2003
6	Opiate Substitution Treatment 01/2021 - 08/2008
5	Secondary Prevention 11/2008 - 01/2002
1	Complementary Therapies (Alternative Medicine) 01/2023